143 related articles for article (PubMed ID: 12072155)
1. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.
Lemmer K; Ahnert-Hilger G; Höpfner M; Hoegerle S; Faiss S; Grabowski P; Jockers-Scherübl M; Riecken EO; Zeitz M; Scherübl H
Life Sci; 2002 Jun; 71(6):667-78. PubMed ID: 12072155
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
3. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells.
Sakolsky DJ; Ashby B
Brain Res Mol Brain Res; 2000 Dec; 84(1-2):158-61. PubMed ID: 11113544
[TBL] [Abstract][Full Text] [Related]
4. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
6. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
7. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
Lee D; Huang W; Lim AT
Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
Sidhu A; Olde B; Humblot N; Kimura K; Gardner N
Neuroscience; 1999; 91(2):537-47. PubMed ID: 10366011
[TBL] [Abstract][Full Text] [Related]
9. Effects of in utero cocaine exposure on the expression of mRNAS encoding the dopamine transporter and the D1, D2 and D5 dopamine receptor subtypes in fetal rhesus monkey.
Choi WS; Rønnekleiv OK
Brain Res Dev Brain Res; 1996 Oct; 96(1-2):249-60. PubMed ID: 8922687
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor subtypes colocalize in rat striatonigral neurons.
Surmeier DJ; Eberwine J; Wilson CJ; Cao Y; Stefani A; Kitai ST
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10178-82. PubMed ID: 1332033
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer.
Cherubini E; Di Napoli A; Noto A; Osman GA; Esposito MC; Mariotta S; Sellitri R; Ruco L; Cardillo G; Ciliberto G; Mancini R; Ricci A
J Cell Physiol; 2016 Feb; 231(2):345-56. PubMed ID: 26081799
[TBL] [Abstract][Full Text] [Related]
13. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.
Hurley MJ; Mash DC; Jenner P
Eur J Neurosci; 2003 Nov; 18(9):2668-72. PubMed ID: 14622169
[TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
15. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Nov; 67(5):1960-4. PubMed ID: 8863501
[TBL] [Abstract][Full Text] [Related]
17. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
Harvey J; Lacey MG
J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
19. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
20. Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain: ribonuclease protection assay analysis.
Choi WS; Machida CA; Ronnekleiv OK
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):86-94. PubMed ID: 7476036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
